U.S. Personal Hygiene Market Size, Share & Forecast 2026–2032

ID: MR-11102 | Published: November 2026
Download PDF Sample

Report Highlights

  • ✓Country: United States
  • ✓Market: Personal Hygiene Market
  • ✓Market Size 2024: USD 38.4 billion
  • ✓Market Size 2032: USD 56.9 billion
  • ✓CAGR: 5.0%
  • ✓Base Year: 2025
  • ✓Forecast Period: 2026–2032
Market Growth Chart
Want Detailed Insights - Download Sample
Analyst Findings and Recommendations
FINDING 01
MoCRA Accelerates Private-Label Consolidation: Smaller contract manufacturers face the steepest compliance cost under MoCRA's safety substantiation rules, forcing private-label brands toward consolidation with larger suppliers such as Kimberly-Clark and Edgewell. Private-label feminine care share will contract as a result before 2027.
FINDING 02
State PFAS Rules Fragment Compliance: Brands assuming MoCRA creates one national standard are mistaken, because Minnesota's Amara's Law and Maine's PFAS in consumer products law impose separate state obligations. Multi-state reformulation in personal hygiene will therefore continue to run on state timetables rather than federal ones.
ANALYST RECOMMENDATION

Analyst Recommendation — Audit PFAS Formulations Now: Brand owners and contract manufacturers should complete PFAS ingredient audits across feminine care and cosmetic-grade wipes within six months, before state enforcement in Minnesota and Maine tightens. Delay risks retailer delisting at Walmart and Target and penalties under state law.

Personal Hygiene in the U.S.: Market Overview

The U.S. personal hygiene market was valued at USD 38.4 billion in 2024 and spans oral care, feminine care, deodorants and antiperspirants, wet wipes, and body cleansing. Mass merchandisers and drug store chains account for the largest share of retail sales, while e-commerce is the fastest-growing channel. Procter & Gamble, Kimberly-Clark, Colgate-Palmolive and Edgewell Personal Care lead product development, brand investment and retail placement. Private sector innovation dominates the commercial market, while government shapes its boundaries.

Government has been the dominant force in defining the market's form through the Federal Food, Drug, and Cosmetic Act of 1938, which gave the Food and Drug Administration authority over cosmetics and OTC antiperspirant monographs. The Coronavirus Aid, Relief, and Economic Security Act of 2020, Section 3851, created the OTC Monograph User Fee Program, allowing faster updates to ingredient standards. Private companies have led on formulation, packaging and direct-to-consumer marketing, with government intervention arriving mainly after product categories reached scale.

Policy-Driven Growth in U.S. Personal Hygiene

The Modernization of Cosmetics Regulation Act of 2022, enacted within Division FF of the Consolidated Appropriations Act 2023, is the most consequential demand driver. Its product listing and safety substantiation requirements raise the compliance threshold, shifting volume toward established brands with regulatory infrastructure and away from small indie labels. This mechanism converts compliance cost into share concentration, lifting revenue for incumbents such as Kimberly-Clark and Colgate-Palmolive. Mandatory recall authority further reinforces trust-driven purchasing in wipes and body cleansers.

California Assembly Bill 10, signed in 2021, requires public middle and high schools to provide free menstrual products, creating a predictable institutional procurement stream. Combined with New York's 2016 sales tax exemption for feminine hygiene products, this policy lowers the effective price paid by consumers and expands use among younger users. Section 3851 of the CARES Act also accelerates OTC monograph updates, letting new antiperspirant actives reach shelves faster.

Regulatory Barriers and Compliance Costs

Antiperspirants are regulated as over-the-counter drugs under 21 CFR Part 350, so manufacturers must meet current good manufacturing practice requirements in 21 CFR Parts 210 and 211. The FDA's Office of Regulatory Affairs enforces these through unannounced inspections, and new drug-grade lines add months to validation timelines. Section 232 aluminum tariffs, raised to 50% in June 2025 and administered by the Department of Commerce with collection by U.S. Customs and Border Protection, have increased the cost of aerosol cans and rigid packaging.

Minnesota's Amara's Law, Minnesota Statutes section 116.943, restricts intentionally added PFAS in cosmetics and other consumer products, with compliance administered by the Minnesota Pollution Control Agency. Maine's PFAS in consumer products law imposes parallel reporting duties enforced by its Department of Environmental Protection. California's Proposition 65 adds labeling exposure, enforced by the Office of Environmental Health Hazard Assessment and private attorneys issuing 60-day notices of violation.

Policy-Created Opportunities in U.S. Personal Hygiene

FDA's proposed asbestos testing requirement for talc-containing cosmetics, issued under its MoCRA authority, creates demand for accredited laboratories capable of polarized light microscopy and transmission electron microscopy. ISO/IEC 17025 accredited testing providers can capture this demand as brands seek documented methods before the expected 2026 finalization. Laboratories that establish validated protocols now will hold a clear commercial position when the final standard takes effect.

California's AB 10 school mandate and similar state programs create an institutional procurement channel for menstrual products that favors suppliers meeting ingredient-disclosure rules under the California Safe Cosmetics Act of 2005. Domestic producers able to certify fluorine-free formulations will win contracts ahead of importers. The EPA Safer Choice Program offers third-party certification that state procurement offices and retailers use to verify wipes and cleansers.

Market at a Glance

IndicatorValue
Market Size 2024USD 38.4 billion
Market Size 2032USD 56.9 billion
Growth Rate (CAGR)5.0%
Most Critical Decision FactorMoCRA and state PFAS compliance readiness
Largest RegionSouth Region (U.S. Census Bureau)
Competitive StructureOligopolistic, with top manufacturers holding majority share

Leading Market Participants

  • Procter & Gamble
  • Kimberly-Clark
  • Colgate-Palmolive
  • Unilever
  • Edgewell Personal Care
  • Church & Dwight
  • Johnson & Johnson
  • Essity
  • Haleon
  • Beiersdorf

Regulatory and Policy Environment

The Modernization of Cosmetics Regulation Act of 2022 is the centerpiece, administered by the Food and Drug Administration's Center for Food Safety and Applied Nutrition. Companies must register manufacturing facilities and list products with FDA, report serious adverse events within 15 business days, and maintain safety substantiation records. Labeling must comply with the Fair Packaging and Labeling Act, enforced by the Federal Trade Commission, and ingredient declarations under 21 CFR Part 701. Small businesses with annual sales under USD 1 million receive partial exemptions from several obligations.

Upcoming changes include FDA's asbestos testing standard for talc-containing cosmetics, expected to be finalized in 2026, and final rules implementing MoCRA's mandatory recall authority. Compared with peers, the U.S. framework relies on post-market enforcement, while the EU's Cosmetics Regulation (EC) No 1223/2009 prohibits more than 1,300 substances and requires a responsible person to hold a safety assessment. Canada's Cosmetic Regulations require notification to Health Canada before sale, placing the U.S. at the lightest pre-market end of the three regimes.

Long-Term Policy Outlook for U.S. Personal Hygiene

By 2032, FDA's MoCRA rulemaking will be complete, bringing mandatory talc testing, recall procedures and standardized adverse event reporting into routine compliance. Congress has not moved to preempt state chemical rules, so further state PFAS restrictions will build a multi-state patchwork that rewards companies with dedicated regulatory teams. Manufacturers will need product-level chemical data for every state in which they sell.

Reshaping forces include tariff-driven packaging costs, growth in fluorine-free formulation, and tighter institutional procurement of menstrual products. Smaller brands will exit or merge as compliance costs scale, increasing the share held by the top manufacturers. Policy will reward verifiable safety data and domestic supply chains, pushing retailer private-label programs toward third-party certification.

Frequently Asked Questions

No, MoCRA does not require FDA pre-market approval for cosmetics. Companies must instead substantiate safety, register facilities and list products with the agency.
Companies must submit serious adverse event reports to FDA within 15 business days under MoCRA. Records supporting these reports must be retained for FDA inspection.
Minnesota restricts intentionally added PFAS under Amara's Law, and Maine enforces its PFAS in consumer products law. Other states are advancing comparable legislation.
Yes, antiperspirants are OTC drugs regulated under 21 CFR Part 350 and must meet FDA monograph requirements. They are also subject to current good manufacturing practice rules.
Yes, Proposition 65 applies to products sold in California that contain listed chemicals above safe harbor levels. Companies must provide clear warnings or face 60-day notices of violation.

Market Segmentation

By Product Type
  • Oral Care
  • Feminine Care
  • Deodorants and Antiperspirants
  • Wet Wipes
  • Body Cleansing
By Distribution Channel
  • Mass Merchandisers
  • Drug Stores
  • Warehouse Clubs
  • E-commerce Platforms
  • Specialty Retailers

Table of Contents

Chapter 01 Methodology and Scope
1.1 Research Methodology
1.2 Scope and Definitions
1.3 Data Sources
Chapter 02 Executive Summary
2.1 Report Highlights
2.2 Market Size and Forecast 2024-2032
Chapter 03 Personal Hygiene in the U.S. - Market Analysis
3.1 Market Overview
3.2 Growth Drivers
3.3 Restraints
3.4 Opportunities
Chapter 04 Product Type Insights
4.1 Oral Care
4.2 Feminine Care
4.3 Deodorants and Antiperspirants
4.4 Wet Wipes
4.5 Others
Chapter 05 Distribution Channel Insights
5.1 Mass Merchandisers
5.2 Drug Stores
5.3 Warehouse Clubs
5.4 E-commerce Platforms
5.5 Others
Chapter 06 Competitive Landscape
6.1 Market Players
6.2 Leading Market Participants
6.2.1 Procter & Gamble
6.2.2 Kimberly-Clark
6.2.3 Colgate-Palmolive
6.2.4 Unilever
6.2.5 Edgewell Personal Care
6.2.6 Church & Dwight
6.2.7 Johnson & Johnson
6.2.8 Essity
6.2.9 Haleon
6.2.10 Beiersdorf
6.3 Regulatory Environment
6.4 Outlook

Research Framework and Methodological Approach

Information
Procurement

Information
Analysis

Market Formulation
& Validation

Overview of Our Research Process

MarketsNXT follows a structured, multi-stage research framework designed to ensure accuracy, reliability, and strategic relevance of every published study. Our methodology integrates globally accepted research standards with industry best practices in data collection, modeling, verification, and insight generation.

1. Data Acquisition Strategy

Robust data collection is the foundation of our analytical process. MarketsNXT employs a layered sourcing model.

Secondary Research
  • Company annual reports & SEC filings
  • Industry association publications
  • Technical journals & white papers
  • Government databases (World Bank, OECD)
  • Paid commercial databases
Primary Research
  • KOL Interviews (CEOs, Marketing Heads)
  • Surveys with industry participants
  • Distributor & supplier discussions
  • End-user feedback loops
  • Questionnaires for gap analysis

Analytical Modeling and Insight Development

After collection, datasets are processed and interpreted using multiple analytical techniques to identify baseline market values, demand patterns, growth drivers, constraints, and opportunity clusters.

2. Market Estimation Techniques

MarketsNXT applies multiple estimation pathways to strengthen forecast accuracy.

Bottom-up Approach

Country Level Market Size
Regional Market Size
Global Market Size

Aggregating granular demand data from country level to derive global figures.

Top-down Approach

Parent Market Size
Target Market Share
Segmented Market Size

Breaking down the parent industry market to identify the target serviceable market.

Supply Chain Anchored Forecasting

MarketsNXT integrates value chain intelligence into its forecasting structure to ensure commercial realism and operational alignment.

Supply-Side Evaluation

Revenue and capacity estimates are developed through company financial reviews, product portfolio mapping, benchmarking of competitive positioning, and commercialization tracking.

3. Market Engineering & Validation

Market engineering involves the triangulation of data from multiple sources to minimize errors.

01 Data Mining

Extensive gathering of raw data.

02 Analysis

Statistical regression & trend analysis.

03 Validation

Cross-verification with experts.

04 Final Output

Publication of market study.

Client-Centric Research Delivery

MarketsNXT positions research delivery as a collaborative engagement rather than a static information transfer. Analysts work with clients to clarify objectives, interpret findings, and connect insights to strategic decisions.